Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96,015,846
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
16,803,742
-
Shares change
-
-1,380,758
-
Total reported value, excl. options
-
$17,812,960
-
Value change
-
-$3,030,205
-
Number of buys
-
13
-
Number of sells
-
-30
-
Price
-
$1.06
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q2 2022
64 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q2 2022.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,803,742 shares
of 96,015,846 outstanding shares and own 18% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (2,541,645 shares), 5AM Venture Management, LLC (2,064,263 shares), SAMLYN CAPITAL, LLC (1,919,907 shares), CITADEL ADVISORS LLC (1,254,479 shares), Cormorant Asset Management, LP (1,154,424 shares), VANGUARD GROUP INC (1,051,838 shares), Ikarian Capital, LLC (944,431 shares), Redmile Group, LLC (696,377 shares), BAKER BROS. ADVISORS LP (662,063 shares), and Kynam Capital Management, LP (546,800 shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.